Nicklas Pihlström

About me
Publications
Public outreach and news

About me

Articles

Journal article: EXPERT REVIEW OF VACCINES. 2024;23(1):1085-1090
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Nunes B; Humphreys J; Nicolay N; Braeye T; Van Evercooren I; Holm Hansen C; Moustsen-Helms IR; Sacco C; Fabiani M; Castilla J; Martínez-Baz I; Meijerink H; Machado A; Soares P; Ljung R; Pihlström N; Nardone A; Bacci S; Monge S; VEBIS-EHR working group
Journal article: BMJ MEDICINE. 2024;3(1):e001074
Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data
Andersson NW; Thiesson EM; Pihlstrom N; Perala J; Faksova K; Gram MA; Poukka E; Leino T; Ljung R; Hviid A
Article: JOURNAL OF INFECTION. 2024;89(4):106261
Comparative effectiveness of bivalent BA.4-5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: A nationwide cohort study
Gram MA; Thiesson EM; Pihlstrom N; Perala J; Poukka E; Leino T; Ljung R; Andersson NW; Hviid A
Article: EUROPEAN HEART JOURNAL. 2024;45(15):1327-1335
Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study
Hviid A; Nieminen TA; Pihlstrom N; Gunnes N; Dahl J; Karlstad O; Gulseth HL; Sundstrom A; Husby A; Hansen JV; Ljung R; Hovi P
Article: PEDIATRICS. 2024;153(2):e2023062520
COVID-19 Vaccine Effectiveness Among Adolescents
Poukka E; Andersson NW; Thiesson EM; Baum U; Pihlstrom N; Perala J; Kristoffersen AB; Meijerink H; Starrfelt J; Ljung R; Hviid A
Article: THE BMJ. 2023;382:e075286
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged?50 years in Nordic countries: nationwide cohort study
Andersson NW; Thiesson EM; Baum U; Pihlstrom N; Starrfelt J; Faksova K; Poukka E; Meijerink H; Ljung R; Hviid A
Article: THE BMJ. 2023;382:e074325
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
Andersson NW; Thiesson EM; Baum U; Pihlstrom N; Starrfelt J; Faksova K; Poukka E; Lund LC; Hansen CH; Aakjaer M; Kjaer J; Cohet C; Goossens M; Andersen M; Hallas J; Meijerink H; Ljung R; Hviid A
Article: BMJ MEDICINE. 2023;2(1):e000373
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
Husby A; Gulseth HL; Hovi P; Hansen JV; Pihlstrom N; Gunnes N; Harkanen T; Dahl J; Karlstad O; Helio T; Kober L; Ljung R; Hviid A
Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2023;128(1)
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines
Gedeborg R; Holm L; Feltelius N; Sundstrom A; Eggers KM; Nurminen M-L; Grunewald M; Pihlstrom N; Zethelius B; Ljung R
Journal article: EUROPEAN UROLOGY OPEN SCIENCE. 2022;42:s13
12 Improved long-term outcome of patients with non-muscle invasive, low and medium risk bladder cancer between 1997 and 2014; A Swedish population-based study
Malmström P-U; Wang EYH; Pihlström N; Gårdmark T
Article: JAMA CARDIOLOGY. 2022;7(6):600-612
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Karlstad O; Hovi P; Husby A; Harkanen T; Selmer RM; Pihlstrom N; Hansen JV; Nohynek H; Gunnes N; Sundstrom A; Wohlfahrt J; Nieminen TA; Grunewald M; Gulseth HL; Hviid A; Ljung R
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2022;56(3):221-226
Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study
Wang EYH; Pihlstrom N; Malmstrom P-U; Gardmark T
Article: BMC MUSCULOSKELETAL DISORDERS. 2021;22(1):872
Factors associated with neck and shoulder pain: a cross-sectional study among 16,000 adults in five county councils in Sweden.
Peterson G; Pihlström N
Article: EPILEPSY RESEARCH. 2020;168:106489
Childhood-onset seizures: A long-term cohort study of use of antiepileptic drugs, and drugs for neuropsychiatric conditions
Andell E; Tomson T; Amark P; Pihlstrom N; Tedroff K; Carlsson S

All other publications

Preprint: MEDRXIV. 2024
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR Network Study
Nunes B; Humphreys J; Nicolay N; Braeye T; Van Evercooren I; Hansen CH; Moustsen-Helms IR; Sacco C; Fabiani M; Castilla J; Martínez-Baz I; Meijerink H; Machado A; Soares P; Ljung R; Pihlström N; Nardone A; Bacci S; Monge S
Preprint: MEDRXIV. 2024
Type 1 diabetes risk and severity after SARS-CoV-2 infection or vaccination
Stene L; Ruiz PL-D; Ljung R; Bøås H; Gulseth H; Pihlström N; Sundström A; Zethelius B; Størdal K; Gani O; Lund-Blix N; Skrivarhaug T; Tapia G
Preprint: MEDRXIV. 2024
Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries
Andersson NW; Thiesson EM; Pihlström N; Perälä J; Faksová K; Gram MA; Poukka E; Leino T; Ljung R; Hviid A
Preprint: MEDRXIV. 2024
Comparative effectiveness of bivalent BA.4.5 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: a nationwide cohort study
Gram MA; Thiesson EM; Pihlström N; Perälä J; Poukka E; Leino T; Ljung R; Andersson NW; Hviid A
Preprint: MEDRXIV. 2023
Comparative effectiveness of the bivalent BA.4-5 and BA.1 mRNA-booster vaccines in the Nordic countries
Andersson NW; Thiesson EM; Baum U; Pihlström N; Starrfelt J; Faksová K; Poukka E; Meijerink H; Ljung R; Hviid A
Preprint: MEDRXIV. 2022
Booster Vaccination with SARS-CoV-2 mRNA Vaccines and Myocarditis Risk in Adolescents and Young Adults: A Nordic Cohort Study of 8.9 Million Residents
Hviid A; Nieminen T; Pihlström N; Gunnes N; Dahl J; Karlstad Ø; Gulseth HL; Sundström A; Husby A; Hansen JV; Ljung R; Hovi P
Preprint: MEDRXIV. 2022
Comparative effectiveness of heterologous booster schedules with AZD1222, BNT162b2, or mRNA-1273 vaccines against COVID-19 during omicron predominance in the Nordic countries
Andersson NW; Thiesson EM; Baum U; Pihlström N; Starrfelt J; Faksová K; Poukka E; Lund LC; Hansen CH; Aakjær M; Kjær J; Cohet C; Goossens M; Andersen M; Hallas J; Meijerink H; Ljung R; Hviid A
Letter: BRITISH JOURNAL OF SURGERY. 2022;109(8):775-776
Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
Ljung R; Pihlstrom N; Sundstrom A

About me

Articles

All other publications

News from KI

Events from KI